https://www.selleckchem.com/pr....oducts/alofanib-rpt8
3 to 5. Intent-to-treat analysis showed a lower level of treatment failure in the DHA-group compared with the control-group (6/105 (6%) vs. 16/109 (15%); p = 0.03, RR = 0.905, (95% CI 0.826 to 0.991)). The results after multivariate-regression analysis remained significant. Adverse events (apart from the incidence of NEC) were not different between groups. A daily dose of DHA for 14 days starting with the first enteral feed may prevent NEC in preterm infants.Aqueduct of Sylvius (AoS) cerebrospinal fluid flow can be quantified
Like
Comment
Share
